(Reuters) – Roche said on Friday that European regulators had recommended approval of its drug Avastin in combination with chemotherapy as a treatment for women with an advanced form of cancer of the cervix.


Avastin, which is already approved in Europe to treat advanced stages of breast cancer, colorectal cancer, non-small cell lung cancer, kidney cancer and ovarian cancer, was the Basel-based drugmaker’s biggest seller last year with sales of 6.42 billion Swiss francs ($ 6.76 billion).


(Reporting By Zurich Slot; Editing by David Goodman)

CervicalCancer – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *